Developing and applying stroke systems of care Andrew M. Demchuk MD - - PowerPoint PPT Presentation

developing and applying stroke systems of care
SMART_READER_LITE
LIVE PREVIEW

Developing and applying stroke systems of care Andrew M. Demchuk MD - - PowerPoint PPT Presentation

Developing and applying stroke systems of care Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Department Head, Dept Clinical Neurosciences HSF Chair in Stroke Research Professor, Depts of Clinical Neurosciences and


slide-1
SLIDE 1

Developing and applying stroke systems of care

Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Deputy Department Head, Dept Clinical Neurosciences HSF Chair in Stroke Research Professor, Depts of Clinical Neurosciences and Radiology Cumming School of Medicine University of Calgary

slide-2
SLIDE 2

Disclosure Slide

  • I have not received an honorarium from Hoffman LaRoche

(licensure of tPA) but have received honorarium from Medtronic (supplier of SOLITAIRE FR stentriever) for CME events

  • No stocks or direct investments with pharmaceutical or device

companies involved in stroke

  • Co-founder/shareholder Quikflo Health start-up (acute stroke

software)

  • Several clinical trial responsibilities:
  • IMS-3- Exec committee, CT core lab PI
  • ESCAPE- Neuro-PI
  • REVASCAT- CT core lab co-PI
  • CLOTBUST-ER – CTA substudy PI
  • ARTSS-2 – CTA substudy core lab PI
  • ENCHANTED – International Advisory Committee
  • PRACTICE- DMC chair
  • DEFUSE 3- Safety monitor
  • ANNEXA-4 – Adjudication committee
slide-3
SLIDE 3

3

Stroke Care Continuum

Stroke Onset EMS Transport ED Time Stroke Team Assessment Imaging Acute Treatment Admission

Clinical Worsening/ Complication Prevention

Rehabilitation Reintegration Secondary Prevention Primary Prevention

slide-4
SLIDE 4

Treatments for Complication Prevention

Stroke units ASA

CT scan Hemicraniectomy

1970 1980 1990 1995 2000 2002 2004 2010 2013 2015

Above knee pneumatic compression stockings Early enteral feeding good

No Early BP lowering

slide-5
SLIDE 5

Per million population

slide-6
SLIDE 6
slide-7
SLIDE 7

Reperfusion Treatment Advances

tPA<3h

CT scan tPA 3-4.5h tPA for elderly

1970 1980 1990 1995 2000 2002 2004 2008 2011 2013 2015

Endovascular tx

Thrombectomy

slide-8
SLIDE 8

Two Decades Behind But Finally an Impactful Treatment

2016 1976

2016

Goyal et al Mechanical Thrombectomy***

slide-9
SLIDE 9

Intravenous rtPA Balance between benefit and risk

slide-10
SLIDE 10

Large clot Proximal artery Severe deficits

10

slide-11
SLIDE 11

SolitaireTM FR TREVO

Thrombectomy: Stent retrieval devices

Thrombus in the stent and aspirate

slide-12
SLIDE 12

10 20 30 40 50 60 70 80 90

Series 3

Series 3

TICI 2b- 3

Stent Retrieval Devices: High Reperfusion Rates

Stroke 2004 1 ; Stroke 2007 2; NEJM 2013 3,4; Lancet 2012 5; Lancet 20126 ; ISC 20127 ; Stroke 20128; ISC 20139

slide-13
SLIDE 13
slide-14
SLIDE 14

14 Independence Dependence

slide-15
SLIDE 15

15

slide-16
SLIDE 16

Shifting the Paradigm in Alberta

Stroke Care in the 21st Century

ESCAPE Inclusion criteria

  • Acute ischemic

stroke (NIHSS > 5)

  • 12 hour window
  • No upper age limit
  • Good functional

status

16

slide-17
SLIDE 17

The 3-5 minute CT/CTA protocol

EIC- ASPECTS Small core >6 Occlusion site M1+/-ICA “Collaterals” good/mod

17

slide-18
SLIDE 18

Overall Results

2016-03-21 www.escapetrial.org 18

29.3% 53.0%

RR: 1.8 (1.4-2.4) NNT = 4.2 [1/0.237]

slide-19
SLIDE 19

Overall Results

19

cOR: 2.6 (1.7-3.8) NNT ~3

slide-20
SLIDE 20

Safety Outcomes

20

Intervention [n=165] Control

[n=150]

RR (CI95) Adjusted§ RR (CI95)

Death [N=311] 10.4% 19.0% 0.5 (0.3-0.95) 0.5 (0.3-0.8) Large/malignant MCA stroke 4.9% 10.7% 0.5 (0.2-1.0) 0.3 (0.1-0.7) sICH (clinically determined

at site)

3.6% 2.7% 1.4 (0.4-4.7) 1.2 (0.3-4.6) Access site hematoma 1.8% 0%

  • MCA perforation

0.6% 0%

  • 6%
slide-21
SLIDE 21

Endovascular thrombectomy after large-vessel ischemic stroke: a meta-analysis of individual patient data from five randomised trials HERMES Collaborators

Highly Effective Reperfusion evaluated in Multiple Endovascular Stroke trials (HERMES)

2016-03-21 HERMES Collaboration 21

slide-22
SLIDE 22

Overall Treatment Effect

2016-03-21 HERMES Collaboration 22

slide-23
SLIDE 23

Overall Treatment Effect NNT = 2.6

2016-03-21 HERMES Collaboration 23

25.5% 46%

slide-24
SLIDE 24

Benefit even if not tPA eligible

2016-03-21 HERMES Collaboration 24

slide-25
SLIDE 25

Patients much improved the next day

2016-03-21 HERMES Collaboration 25

slide-26
SLIDE 26

No increased bleeding Reduction in Mortality trend

2016-03-21 HERMES Collaboration 26

slide-27
SLIDE 27

Treatment effect by age mRS 0-2 at 90 days

2016-03-21 HERMES Collaboration 27

slide-28
SLIDE 28

Effect size by NIHSS

2016-03-21 HERMES Collaboration 28

slide-29
SLIDE 29

Treatment effect is strongest if carotid occlusion (pint=0.17)

2016-03-21 HERMES Collaboration

slide-30
SLIDE 30

Treatment effect is strong if cervical ICA too (pint=0.17)

2016-03-21 HERMES Collaboration

slide-31
SLIDE 31

Onset to Substantial Reperfusion and Disability Outcomes (mRS) at 3 Months

2016-03-21 HERMES Collaboration 31

slide-32
SLIDE 32

Onset to Randomization and Disability Outcomes (mRS) at 3 Months

2016-03-21 HERMES Collaboration 32

3-5% absolute decrease in good outcome per hour 1-2% absolute increase in mortality per hour

slide-33
SLIDE 33

~1 in 4 or 5 strokes = EVT accessible occlusion 100-150 endo eligible/1 million/yr

What is the potential for EVT?

slide-34
SLIDE 34

During this Morning Somewhere in Western Canada…. At least one individual has suffered a major ischemic stroke that is very suitable for endovascular rescue if….

slide-35
SLIDE 35

Endovascular Treatment How Do We Build The System of Care To Do This?

slide-36
SLIDE 36

~40 PCI Facilities in Canada

for Acute Myocardial Infarction

slide-37
SLIDE 37

Is Your Region Equipped with Stroke Thrombectomy Facilities Nearby?

Are there neurointerventionalists available 24h/365d at these facilities?

slide-38
SLIDE 38

The How To?

  • EMS transport to right hospital
slide-39
SLIDE 39

How are ambulances routing hyperacute major deficit patients?

PSC CSC PSC PSC EMS transport to any hospital should be unacceptable!

slide-40
SLIDE 40

Centralize care: Redirect ambulance to stroke centre

PSC CSC PSC PSC

slide-41
SLIDE 41

US Model of Hubs and Spoke Model

slide-42
SLIDE 42

42

“Time is Brain”

Primary Stroke Centre (PSC) Criteria: CT scan availability Door to CT time less than 20 minutes with pre-alert Stroke expertise on-site or available by Telestroke link rtPA treatment availability Serves all surrounding communities in which it is the nearest PSC Comprehensive Stroke Centre (CSC) Criteria: CT scan availability Door to CT time less than 20 minutes with pre-alert Stroke team on-site Neurosurgical expertise on-site Neuro-interventionist expertise on-site Central hub of stroke neurologist expertise in a telestroke network

Stroke Centre Designation Criteria

slide-43
SLIDE 43

43

Alberta Acute Stroke Treatment 2016

Comprehensive Stroke Centre Primary Stroke Centre

slide-44
SLIDE 44
slide-45
SLIDE 45

Transport decisions evolving

slide-46
SLIDE 46

Transport decisions evolving

angio EVT

slide-47
SLIDE 47

The How To?

  • EMS transport to right hospital
  • Primary Stroke Centres
  • CT/CTA 24/7
  • Telestroke capability to hub CSC
slide-48
SLIDE 48

Mechanical thrombectomy Ideal If

M1 MCA Occlusion Carotid Occlusion

slide-49
SLIDE 49

NCCT/CTA now standard of care and should be performed sequentially while on CT table

49

slide-50
SLIDE 50

“Neurons over nephrons” in major stroke

slide-51
SLIDE 51

“CIN” called into question

slide-52
SLIDE 52

Primary Stroke Centre Model with Telestroke

slide-53
SLIDE 53

The How To?

  • EMS transport to right hospital
  • Primary Stroke Centres
  • CT/CTA 24/7
  • Telestroke capability to hub CSC
  • DTN<30 min
  • DIDO <45 min
slide-54
SLIDE 54
slide-55
SLIDE 55

Target: Stroke Best Practice Strategies

  • 1. *EMS Pre-Notification
  • 2. Stroke Toolkit
  • 3. Rapid Triage and

Stroke Team Notification

  • 4. *Single Call Activation

System

  • 5. *Transfer Directly to CT
  • 6. Rapid Brain Imaging
  • 7. *POC Laboratory

Testing

  • 8. *Premix TPA
  • 9. *Rapid TPA Access -

store TPA in ED/radiology, start in imaging suite 10.Team approach 11.*Prompt data feedback

slide-56
SLIDE 56

STAT! STROKE Prehospital Notification

Stroke neurologist Triage nurse ED physician CT tech Patient care attendant ED bedside nurse Angio team Neuro-IR

slide-57
SLIDE 57 Phase 2 Phase 1 Phase 2 Phase 3

NCCT CTA

Keep on the CT table for immediate CTA!

NCCT prep/scanning time <5 min

CTA

NCCT to tPA decision via telestroke <10 min mix/prep for bolus <5 min Door to CT scanner <10 min CTA prep/scanning time <5 min CTA reformatting time <5 min All images to decision <10 min

DTN <30 min/ DIDO <45 min

Decision to door out <10 min

Keep on EMS stretcher!

Door in door out <45 minutes Door to needle <30 minutes

57

slide-58
SLIDE 58

LSN Time EMS Activation First door in CT/CTA IV tPA start time First Door Out Second door in Repeat CT/CTA Groin Puncture

Revasculariz

  • ation

Second door

  • ut

Home time % in first 90 days

FUTURE

58

slide-59
SLIDE 59

The How To?

  • EMS transport to right hospital
  • Primary Stroke Centres
  • CT/CTA 24/7
  • Telestroke capability to hub CSC
  • DTN<30 min
  • DIDO <45 min
  • Comprehensive Stroke Centre
  • Bypass of PSCs if severe+by distance
slide-60
SLIDE 60

Onset to Substantial Reperfusion and Disability Outcomes (mRS) at 3 Months

2016-03-21 HERMES Collaboration 60

slide-61
SLIDE 61

61

slide-62
SLIDE 62

Transport decisions evolving

angio EVT

slide-63
SLIDE 63

Transport decisions evolving

angio EVT

slide-64
SLIDE 64

Transport decisions evolving

angio EVT

slide-65
SLIDE 65

What to do when more than one stroke centre in metro area?

PSC CSC PSC PSC

slide-66
SLIDE 66

Golden 2 Hours of Stroke

2016-03-21 HERMES Collaboration 66

P=0.001

66.9% 8.3%

slide-67
SLIDE 67

2016-03-21 HERMES Collaboration 67

207 65 15 21 29 50 31 32 47 42 Transfer Direct admit

Workflow Times in Direct and Transfer Patients

(minutes, medians) Onset to ED ED to imaging start Imaging to randomization Randomization to puncture Puncture to reperfusion

slide-68
SLIDE 68

Baseline Characteristics Differed by Time Window of Randomization

30-120 mins 121-240 mins 241-360 mins >360 mins N 194 657 352 79 Age 68.7 66.5 65.8 64.5 Sex (female) 53.1% 46.0% 44.7% 53.2% NIHSS 17.2 17.0 16.5 16.1 Direct (vs transfer) 97.9% 75.5% 37.8% 66.7% IV tPA 85.6% 89.0% 86.9% 45.6% Location ICA 32.1% 21.8% 16.2% 21.8% M1 62.2% 70.2% 76.2% 71.8% ASPECTS 9.0 8.4 7.8 8.0 2016-03-21 HERMES Collaboration 68

slide-69
SLIDE 69
slide-70
SLIDE 70
slide-71
SLIDE 71
slide-72
SLIDE 72

72

Alberta Acute Stroke Treatment 2016

Comprehensive Stroke Centre Primary Stroke Centre

slide-73
SLIDE 73

3 way onscene communication for rural areas

  • LAMSS >4 + <6h/wakeups
  • EMS provider at scene
  • Comprehensive stroke centre team
  • Transport physician
slide-74
SLIDE 74

The Conversation at Scene

Truly Hemiplegic? Helicopter available? Weather? Transport times to PSC vs CSC? Last seen normal? tPA ineligible? Clinically worsening? ICH? Premorbid status? Should ambulance rendezvous with helicopter? PSC operational?

DECISION! GO!

slide-75
SLIDE 75

Optimize NCCT mCTA with thick MIPs Pr

CTA 23 mm Thick MIPs

1223h

mCTA CTA neck/head Thin section NCCT Quality NCCT

slide-76
SLIDE 76

mCTA with thick MIPs Protocol

1223h

slide-77
SLIDE 77

Fast DTNs translate to fast DTGP times

Median DtoGP: 60 66 60 62 47 25th% DtoGP: 44 42 46 35 30

slide-78
SLIDE 78

Thank-you for your attention!